BMRN (BioMarin Pharma) Bozor qiymatining balans qiymatiga nisbati

BioMarin Pharma (BMRN) - korporativ logo

BioMarin Pharmaceutical (BMRN) dori vositalari sintezini tezlashtirish uchun sun'iy intellektni joriy qilmoqda va buni toza xonalardagi robotlashtirilgan ferment dozalash tizimi bilan to'ldirmoqda. Biznes samaradorligi monopol narxlar va Voxzogo savdolariga asoslangan. Kitob qiymatiga nisbat ko'rsatkichi aktivlar marjasiga bozorning reaksiyasini aks ettiradi, bunda 1.67 belgisi joriy real vaqt baholash metriki vazifasini bajaradi.

Sof aktivlarga nisbatan bozor kapitallashuvi: BioMarin Corp (BMRN) 04.07.2022 - 28.10.2026 uchun
BioMarin Pharmaceutical Inc. tayyor mahsulotlari

Professional menejerlar bozor qiymati va korxonaning real kapitali o'rtasidagi farqni tahlil qilish orqali haddan tashqari qimmat baholangan aktivlarni aniqlash uchun fundamental filtrlardan foydalanadilar. Ushbu metrika aktivlardagi spekulyativ premium darajasini o'lchaydi, bu esa butun umr davomida talab mavjud bo'lgan kamyob dori vositalari sektoridagi monopolist bo'lgan BioMarin Pharmaceutical (BMRN) uchun kompaniyaning joriy bozor narxining uning sof balans qiymatiga nisbati orqali kirish nuqtasini aniqlashda juda muhimdir.

Toʻgʻridan-toʻgʻri raqobatchilar

Bozor qiymatining balans qiymatiga nisbati Vertex Pharmaceuticals|ALNY (alnylam.com) - Kapitallashuvning balans qiymatiga nisbati|INSM: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi UTHR|BBIO - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi bgm.ltd (BGM)|COGT: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti xerispharma.com XERS|KROS: Bozor kapitallashuvining balans qiymatiga nisbati|ARCT - Kapitallashuvning sof aktivlarga nisbati|Eton Pharma - Bozor kapitallashuvining balans qiymatiga nisbati|Kamada Pharma (KMDA) - Balans qiymatiga nisbatan bozor kapitallashuvi|FULC (Fulcrum Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ABEO|Bozor qiymatining balans qiymatiga nisbati Mereo BioPharma (MREO)|Bozor qiymatining balans qiymatiga nisbati Protalix BioTherapeutics Inc. (PLX)|Bozor kapitallashuvining balans qiymatiga nisbati PLRX|APLT - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati Rein Therapeutics Inc|GELS - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati AYTU|Chemomab Therapeutics Ltd. (CMMB) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati SRx Health Solutions Inc (SRXH)|Kapitallashuvning balans qiymatiga nisbati Polyrizon Ltd. (PLRZ)|Aeterna Zentaris (AEZS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati CYTH (cyclotherapeutics.com)|Inozyme Pharma (INZY) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Reneo Pharmaceuticals Inc. RPHM|Bozor kapitallashuvining balans qiymatiga nisbati Aeterna Zentaris (CSCI)